Eckhardt Sue Gail 4

What Happened
Director Sue (Eckhardt) Gail sold 3,856 shares of Exelixis (EXEL) in an open-market sale on February 13, 2026. The weighted average sale price was $43.79, for total proceeds of approximately $168,854. This was a sale (not a purchase or grant).

Key Details

• Transaction date: 2026-02-13; Form 4 filed: 2026-02-18. (Standard Form 4 deadline is two business days; filing is 5 calendar days after the trade — see filing for timeliness flag.)
• Price: weighted average $43.79; individual trade prices ranged $42.89–$43.89. Reporting person can provide per-price breakdown on request (footnote).
• Shares sold: 3,856 (code S — sale). Total value ≈ $168,854.
• Shares owned after transaction: not specified in the provided excerpt; filing notes inclusion of 17,524 unvested RSUs (see footnote).
• Notable footnotes:
  • F1: Sales were effected under a Rule 10b5-1 trading plan adopted Nov 11, 2025.
  • F2: Weighted-average price; multiple trades within $42.89–$43.89.
  • F3: Filing references 17,524 restricted stock units that will convert to shares upon vesting.

Context
A 10b5-1 plan indicates the sales were pre‑planned and executed under an established trading arrangement, which often (but not always) suggests the transactions were routine rather than prompted by new private information. The RSUs referenced are unvested awards that will become shares upon vesting and are reported separately from the sale. Check the full Form 4 for exact post‑transaction holdings and any timeliness designation.